BMP2 and cancer: Holtzhausen et al. used a variety of techniques to show that BMP2 could induce heterodimeric type I receptor complexes composed of ALK5/7 and ALK3/6, which were capable of phosphorylating SMAD2/3 in a variety of cancer cell lines18.